| MAP kinase signalling pathways in cancer AS Dhillon, S Hagan, O Rath, W Kolch Oncogene 26 (22), 3279-3290, 2007 | 3560 | 2007 |
| Raf kinase inhibitor protein interacts with NF-κB-inducing kinase and TAK1 and inhibits NF-κB activation KC Yeung, DW Rose, AS Dhillon, D Yaros, M Gustafsson, D Chatterjee, ... Molecular and cellular biology 21 (21), 7207-7217, 2001 | 495 | 2001 |
| Regulation of Raf‐1 activation and signalling by dephosphorylation AS Dhillon, S Meikle, Z Yazici, M Eulitz, W Kolch The EMBO journal, 2002 | 391 | 2002 |
| Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259 AS Dhillon, C Pollock, H Steen, PE Shaw, H Mischak, W Kolch Molecular and cellular biology 22 (10), 3237-3246, 2002 | 314 | 2002 |
| Untying the regulation of the Raf-1 kinase AS Dhillon, W Kolch Archives of biochemistry and biophysics 404 (1), 3-9, 2002 | 251 | 2002 |
| Snail is a repressor of RKIP transcription in metastatic prostate cancer cells S Beach, H Tang, S Park, AS Dhillon, ET Keller, W Kolch, KC Yeung Oncogene 27 (15), 2243-2248, 2008 | 245 | 2008 |
| Dystroglycan, a scaffold for the ERK–MAP kinase cascade HJ Spence, AS Dhillon, M James, SJ Winder EMBO reports 5 (5), 484-489, 2004 | 202 | 2004 |
| Phenotype switching in melanoma: implications for progression and therapy FZ Li, AS Dhillon, RL Anderson, G McArthur, PT Ferrao Frontiers in oncology 5, 31, 2015 | 193 | 2015 |
| Regulation of the Raf–MEK–ERK pathway by protein phosphatase 5 A Von Kriegsheim, A Pitt, GJ Grindlay, W Kolch, AS Dhillon Nature cell biology 8 (9), 1011-1016, 2006 | 173 | 2006 |
| Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells CB Pollock, S Shirasawa, T Sasazuki, W Kolch, AS Dhillon Cancer research 65 (4), 1244-1250, 2005 | 150 | 2005 |
| The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma R Ramsdale, RN Jorissen, FZ Li, S Al-Obaidi, T Ward, KE Sheppard, ... Science signaling 8 (390), ra82-ra82, 2015 | 135 | 2015 |
| Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL AE Sayan, R Stanford, R Vickery, E Grigorenko, J Diesch, K Kulbicki, ... Oncogene 31 (12), 1493-1503, 2012 | 123 | 2012 |
| Dual targeting of bromodomain and extraterminal domain proteins, and WNT or MAPK signaling, inhibits c-MYC expression and proliferation of colorectal cancer cells L Tögel, R Nightingale, AC Chueh, A Jayachandran, H Tran, T Phesse, ... Molecular cancer therapeutics 15 (6), 1217-1226, 2016 | 97 | 2016 |
| Phosphatase and feedback regulation of Raf-1 signaling AS Dhillon, A Von Kriegsheim, J Grindlay, W Kolch Cell Cycle 6 (1), 3-7, 2007 | 86 | 2007 |
| Widespread FRA1-dependent control of mesenchymal transdifferentiation programs in colorectal cancer cells J Diesch, E Sanij, O Gilan, C Love, H Tran, NI Fleming, J Ellul, M Amalia, ... PloS one 9 (3), e88950, 2014 | 85 | 2014 |
| Alcoholic myopathy: biochemical mechanisms VR Preedy, A Paice, D Mantle, AS Dhillon, TN Palmer, TJ Peters Drug and alcohol dependence 63 (3), 199-205, 2001 | 78 | 2001 |
| FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer AS Dhillon, E Tulchinsky Oncogene 34 (34), 4421-4428, 2015 | 75 | 2015 |
| Oncogenic B-Raf mutations: crystal clear at last AS Dhillon, W Kolch Cancer cell 5 (4), 303-304, 2004 | 74 | 2004 |
| A novel role for the Pol I transcription factor UBTF in maintaining genome stability through the regulation of highly transcribed Pol II genes E Sanij, J Diesch, A Lesmana, G Poortinga, N Hein, G Lidgerwood, ... Genome research 25 (2), 201-212, 2015 | 70 | 2015 |
| A Raf-1 mutant that dissociates MEK/extracellular signal-regulated kinase activation from malignant transformation and differentiation but not proliferation AS Dhillon, S Meikle, C Peyssonnaux, J Grindlay, C Kaiser, H Steen, ... Molecular and cellular biology, 2003 | 68 | 2003 |
